Vanguard Group Inc Alector, Inc. Transaction History
Vanguard Group Inc
- $5.46 Trillion
- Q3 2024
A detailed history of Vanguard Group Inc transactions in Alector, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 5,455,727 shares of ALEC stock, worth $10.1 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,455,727
Previous 5,320,970
2.53%
Holding current value
$10.1 Million
Previous $24.2 Million
5.47%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding ALEC
# of Institutions
168Shares Held
57.8MCall Options Held
146KPut Options Held
90.8K-
Black Rock Inc. New York, NY9.1MShares$16.9 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.63MShares$8.62 Million0.8% of portfolio
-
Morgan Stanley New York, NY4.36MShares$8.1 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY2.73MShares$5.08 Million0.0% of portfolio
-
State Street Corp Boston, MA2.62MShares$4.87 Million0.0% of portfolio
About Alector, Inc.
- Ticker ALEC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 82,563,904
- Market Cap $154M
- Description
- Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...